Since it can effectively inhibit the migration and viability of CRC cells and promote apoptosis (Tian et al., 2018; Zhang et al., 2019), icariin has been shown to have an antitumor effect on CRC in a p53-dependent manner (Tian et al., 2018). The gene discussed is TP53; the disease is colorectal carcinoma.